v3.20.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Total revenues $ 18,389 $ 20,857 $ 90,171 $ 43,888
Costs and expenses:        
Cost of product sales 140 310 574 728
Research and development 14,600 14,463 44,963 38,638
Selling, general and administrative 17,430 18,121 54,780 56,276
Total costs and expenses 32,170 32,894 100,317 95,642
Loss from operations (13,781) (12,037) (10,146) (51,754)
Interest income 36 555 563 2,068
Interest expense (429) (8) (924) (8)
Net loss $ (14,174) $ (11,490) $ (10,507) $ (49,694)
Net loss per share, basic and diluted        
Net loss per share, basic and diluted (in dollars per share) $ (0.08) $ (0.07) $ (0.06) $ (0.30)
Weighted average shares used in computing net loss per share        
Weighted average shares used in computing net loss per share, basic and diluted (in shares) 168,932 167,609 168,658 167,326
Product sales, net        
Total revenues $ 16,289 $ 11,716 $ 43,943 $ 29,943
Contract revenues from collaborations        
Total revenues $ 2,100 $ 9,141 $ 46,228 $ 13,945

Source